Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Johanna C. Bendell | Researchclopedia

Back to researchers

Johanna C. Bendell

Sarah Cannon ORCID

928

Works

30,331

Citations

82

h-index

349

i10-index

Research Topics

Colorectal Cancer Treatments and Studies Cancer Immunotherapy and Biomarkers Lung Cancer Treatments and Mutations

Affiliations

Roche (Switzerland)2021–2024

West Virginia University2006–2008

Indiana University Health2011–2015

Novartis (Switzerland)2011–2014

Massachusetts Eye and Ear Infirmary2012–2012

Top Works

Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer

Thierry André,Kai‐Keen Shiu,et al.

20202,826 citations

Gastric Cancer Management and Outcomes

Cancer Treatment and Pharmacology

Central nervous system metastases in women who receive trastuzumab‐based therapy for metastatic breast carcinoma

Johanna C. Bendell,Susan M. Domchek,et al.

20031,317 citations

Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial

Scott Antonia,José A. López-Martín,et al.

20161,248 citations

Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma

Jeffrey J. Wallin,Johanna C. Bendell,et al.

2016703 citations

Phase I, Dose-Escalation Study of BKM120, an Oral Pan-Class I PI3K Inhibitor, in Patients With Advanced Solid Tumors

Johanna C. Bendell,Jordi Rodón,et al.

2011683 citations

CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer

Yelena Y. Janjigian,Johanna C. Bendell,et al.

2018626 citations

Combined BRAF, EGFR, and MEK Inhibition in Patients with <i>BRAF</i> V600E-Mutant Colorectal Cancer

Ryan B. Corcoran,Thierry André,et al.

2018574 citations

Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study

Michael S. Lee,Baek‐Yeol Ryoo,et al.

2020561 citations

Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial

Jeffrey R. Infante,Leslie A. Fecher,et al.

2012554 citations